{"nct_id":"NCT03010176","title":"Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)","status":"COMPLETED","status_verified_date":"2024-02","start_date":"2017-02-03","start_date_type":"ACTUAL","primary_completion_date":"2022-04-21","primary_completion_date_type":"ACTUAL","completion_date":"2022-04-21","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}